Federal Register / Vol. 77, No. 11 / Wednesday, January 18, 2012 / Notices 2557 

and need to be better understood by 

ethicists, researchers, policymakers, and 

the general public. The purpose of the 

public workshop is to provide a forum 

for careful consideration of scientific, 

ethical, and regulatory issues 

confronting FDA and other stakeholders 

in the area of medical countermeasures 

and public health preparedness. 

Date and Time: The public workshop 

will be held on February 15, 2012, from 

8:30 a.m. to 5 p.m. and February 16, 

2012, from 8:30 a.m. to 3 p.m. 

Location: The public workshop will 

be held at the Rockville Hilton Hotel, 

1750 Rockville Pike, Rockville, MD 

20852. 

Contact Person: Cindy de Sales, (240) 

316–3207, FAX: (240) 316–3201, email: 

cindy@tepgevents.com. 

Registration: Please use the following 

Web site to register online: http:// 

www.contractmeetings.com. 

Alternatively, you can email or fax your 

registration information (including 

name, title, firm name, address, 

telephone and fax numbers) to the 

contact person by February 1, 2012. 

There is no registration fee for the 

public workshop. Early registration is 

recommended because seating is 

limited. Registration on the day of the 

public workshop will be provided on a 

space available basis beginning at 8 a.m. 

If you need special accommodations 

due to a disability, please contact Cindy 

de Sales (see Contact Person) at least 

7 days in advance. 

SUPPLEMENTARY INFORMATION: The 

workshop will include plenaries and 

breakout sessions on the ethical and 

regulatory challenges in the 

development of medical 

countermeasures for the pediatric 

population. Topics of the breakout 

sessions will include: (1) Institutional 

Review Board preparedness to review 

study protocols relevant to pediatric 

medical countermeasures; (2) potential 

scientific and ethical justifications for 

conducting pre-event pediatric medical 

countermeasures research; (3) leveraging 

new technologies to develop pediatric 

medical countermeasures; and (4) risk 

communication related to pediatric 

treatment and research during public 

health emergencies. The workshop also 

will include discussion of a number of 

case studies to facilitate discussion of 

the challenges of pediatric medical 

countermeasure development and 

deployment. 

Transcripts: Transcripts of the public 

workshop may be requested in writing 

from the Division of Freedom of 

Information (ELEM–1029), Food and 

Drug Administration, 12420 Parklawn 

Dr., Element Bldg., Rockville, MD 

20857, approximately 15 working days 

after the public workshop at the cost of 

10 cents per page. A transcript of the 

public workshop will be available on 

the Internet at http:// 

www.regulations.gov, Docket No. FDA– 

2011–N–0002. Transcripts may also be 

viewed at the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. 

Dated: January 12, 2012. 

David Dorsey, 

Acting Associate Commissioner for Policy and 

Planning. 

[FR Doc. 2012–846 Filed 1–17–12; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

National Cancer Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4), and 552b(c)(6), Title 5 

U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Advisory Board Ad hoc Subcommittee on 

Global Cancer Research. 

Open: February 27, 2012, 6:30 p.m. to 

8 p.m. 

Agenda: Discussion on Global Cancer. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, Maryland 

20814. 

Contact Person: Dr. Ted Trimble, Executive 

Secretary, NCAB Ad hoc Subcommittee on 

Global Cancer Research, National Cancer 

Institute, National Institutes of Health, 6130 

Executive Boulevard, EPN/7025, Rockville, 

MD 20892–8345, (301) 496–2522, 

trimblet@mail.nih.gov. 

Name of Committee: National Cancer 

Advisory Board. 

Open: February 28, 2012, 9 a.m. to 

3:30 p.m. 

Agenda: Program reports and 

presentations; business of the Board. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Closed: February 28, 2012, 3:30 p.m. to 5 

p.m. 

Agenda: Review of grant applications. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Open: February 29, 2012, 9 a.m. to 12 p.m. 

Agenda: Program reports and 

presentations; business of the Board. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/ncab.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 


tkelley on DSK3SPTVN1PROD with NOTICES
2558 Federal Register / Vol. 77, No. 11 / Wednesday, January 18, 2012 / Notices 

Dated: January 11, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy . 

[FR Doc. 2012–869 Filed 1–17–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2011–0108] 

RIN 1601–ZA11 

Identification of Foreign Countries 

Whose Nationals Are Eligible To 

Participate in the H–2A and H–2B 

Nonimmigrant Worker Programs 

AGENCY: Office of the Secretary, DHS. 

ACTION: Notice. 

SUMMARY: Under Department of 

Homeland Security (DHS) regulations, 

U.S. Citizenship and Immigration 

Services (USCIS) may approve petitions 

for H–2A and H–2B nonimmigrant 

status only for nationals of countries 

that the Secretary of Homeland Security, 

with the concurrence of the Secretary of 

State, has designated by notice 

published in the Federal Register. That 

notice must be renewed each year. This 

notice announces that the Secretary of 

Homeland Security, in consultation 

with the Secretary of State, is 

identifying 58 countries whose 

nationals are eligible to participate in 

the H–2A and H–2B programs for the 

coming year. New countries on this 

year’s list include Haiti, Iceland, 

Montenegro, Spain, and Switzerland. 

DATES: Effective Date: This notice is 

effective January 18, 2012, and shall be 

without effect at the end of one year 

after January 18, 2012. 

FOR FURTHER INFORMATION CONTACT: 

Francis Cissna, Office of Policy, 

Department of Homeland Security, 

Washington, DC 20528, (202) 447–3835. 

SUPPLEMENTARY INFORMATION: 

Background: USCIS generally may 

approve H–2A and H–2B petitions only 

for nationals of countries that the 

Secretary of Homeland Security, with 

the concurrence of the Secretary of 

State, has designated as participating 

countries. Such designation must be 

published as a notice in the Federal 

Register and expires after one year. 

USCIS may, however, allow a national 

from a country not on the list to be 

named as a beneficiary of an H–2A or 

H–2B petition based on a determination 

that such participation is in the U.S. 

interest. See 8 CFR 214.2(h)(5)(i)(F) and 

8 CFR 214.2(h)(6)(i)(E). 

In designating countries to include on 

the list, the Secretary of Homeland 

Security, with the concurrence of the 

Secretary of State, will take into account 

factors including, but not limited to: (1) 

The country’s cooperation with respect 

to issuance of travel documents for 

citizens, subjects, nationals, and 

residents of that country who are subject 

to a final order of removal; (2) the 

number of final and unexecuted orders 

of removal against citizens, subjects, 

nationals, and residents of that country; 

(3) the number of orders of removal 

executed against citizens, subjects, 

nationals, and residents of that country; 

and (4) such other factors as may serve 

the U.S. interest. See 8 CFR 

214.2(h)(5)(i)(F)(1)(i) and 8 CFR 

214.2(h)(6)(i)(E)(1). 

In December 2008, DHS published in 

the Federal Register two notices, 

‘‘Identification of Foreign Countries 

Whose Nationals Are Eligible to 

Participate in the H–2A Visa Program,’’ 

and ‘‘Identification of Foreign Countries 

Whose Nationals Are Eligible to 

Participate in the H–2B Visa Program,’’ 

which designated 28 countries whose 

nationals are eligible to participate in 

the H–2A and H–2B programs. See 73 

FR 77,043 (Dec. 18, 2008); 73 FR 77,729 

(Dec. 19, 2008). The notices ceased to 

have effect on January 17, 2010 and 

January 18, 2010, respectively. See 

8 CFR 214.2(h)(5)(i)(F)(2) and 8 CFR 

214.2(h)(6)(i)(E)(3). 

To allow for the continued operation 

of the H–2A and H–2B programs, the 

Secretary of Homeland Security 

published, with the concurrence of the 

Secretary of State, a notice in the 

Federal Register on January 19, 2010, 

‘‘Identification of Foreign Countries 

Whose Nationals Are Eligible to 

Participate in the H–2A and H–2B 

Programs.’’ The notice provided for the 

continued eligibility of the 28 countries 

initially listed in the Federal Register 

notices of December 18 and December 

19, 2008, and added 11 additional 

countries. See 75 FR 2,879 (Jan. 19, 

2010). A notice in the Federal Register 

on January 18, 2011, ‘‘Identification of 

Foreign Countries Whose Nationals Are 

Eligible to Participate in the H–2A and 

H–2B Programs,’’ provided for the 

continued eligibility of 38 of the 

countries listed in the 2010 notice, 

removed Indonesia from the list, as 

Indonesia was not meeting the 

standards set forth in the regulation, and 

added 15 countries. See 76 FR 2,915 

(Jan. 18, 2011). 

The Secretary of Homeland Security 

has determined, with the concurrence of 

the Secretary of State, that the 53 

countries previously designated in the 

January 18, 2011 notice continue to 

meet the standards identified in that 

notice for eligible countries and 

therefore should remain designated as 

countries whose nationals are eligible to 

participate in the H–2A and H–2B 

programs. Further, the Secretary of 

Homeland Security, with the 

concurrence of the Secretary of State, 

has determined that it is now 

appropriate to add five additional 

countries to the list of countries whose 

nationals are eligible to participate in 

the H–2A and H–2B programs. This 

determination is made taking into 

account the four factors identified 

above. The Secretary of Homeland 

Security also considered other pertinent 

factors including, but not limited to, 

evidence of past usage of the H–2A and 

H–2B programs by nationals of the 

countries to be added, as well as 

evidence relating to the economic 

impact on particular U.S. industries or 

regions resulting from the addition or 

continued non-inclusion of specific 

countries. In consideration of all of the 

above, this notice designates for the first 

time Haiti, Iceland, Montenegro, Spain, 

and Switzerland as countries whose 

nationals are eligible to participate in 

the H–2A and H–2B programs. 

Designation of Countries Whose 

Nationals Are Eligible To Participate in 

the H–2A and H–2B Nonimmigrant 

Worker Programs 

Pursuant to the authority provided to 

the Secretary of Homeland Security 

under sections 214(a)(1), and 215(a)(1) 

and 241 of the Immigration and 

Nationality Act (8 U.S.C. 1184(a)(1), 

1185(a)(1), and 1231), I have designated, 

with the concurrence of the Secretary of 

State, that nationals from the following 

countries are eligible to participate in 

the H–2A and H–2B non-immigrant 

worker programs: 

Argentina 

Australia 

Barbados 

Belize 

Brazil 

Bulgaria 

Canada 

Chile 

Costa Rica 

Croatia 

Dominican Republic 

Ecuador 

El Salvador 

Estonia 

Ethiopia 

Fiji 

Guatemala 

Haiti 

Honduras 

Hungary 

Iceland 

Ireland 

Israel 

Jamaica 


tkelley on DSK3SPTVN1PROD with NOTICES